drugset / Trial / NCT05067387

Evaluation of Oral THC and CBD in Men and Women

NCT05067387

Phase 1 Not yet recruiting 22 enrolled University of California, Los Angeles
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to determine the pharmacokinetics and pharmacodynamics of oral delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) and to evaluate detection of recently smoked THC in oral fluid.

Timeline

Start
2026-07-15
Primary completion
2027-06-15
Completion
2028-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 20 mg Oral
Subject delta-9-tetrahydrocannabinol Other / unclassified 20 mg Oral